Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2005 1
2006 3
2007 5
2008 2
2009 1
2012 2
2013 2
2015 3
2016 2
2017 1
2018 1
2019 2
2020 2
2021 1
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Association of Serum Neurofilament Light Chain Levels at Disease Onset With Disability Worsening in Patients With a First Demyelinating Multiple Sclerosis Event Not Treated With High-Efficacy Drugs.
Monreal E, Fernández-Velasco JI, García-Sánchez MI, Sainz de la Maza S, Llufriu S, Álvarez-Lafuente R, Casanova B, Comabella M, Ramió-Torrentà L, Martínez-Rodríguez JE, Brieva L, Saiz A, Eichau S, Cabrera-Maqueda JM, Villarrubia N, Espiño M, Pérez-Miralles F, Montalbán X, Tintoré M, Quiroga-Varela A, Domínguez-Mozo MI, Rodríguez-Jorge F, Chico-García JL, Lourido D, Álvarez-Cermeño JC, Masjuan J, Costa-Frossard L, Villar LM. Monreal E, et al. JAMA Neurol. 2023 Apr 1;80(4):397-403. doi: 10.1001/jamaneurol.2023.0010. JAMA Neurol. 2023. PMID: 36848127 Free PMC article.
[Narcolepsy].
Martínez-Rodríguez JE, Iranzo A, Santamaría J. Martínez-Rodríguez JE, et al. Med Clin (Barc). 2002 Nov 30;119(19):749-54. Med Clin (Barc). 2002. PMID: 12487973 Review. Spanish. No abstract available.
Treatment of multiple sclerosis with rituximab: A Spanish multicenter experience.
Gascón-Giménez F, Alcalá C, Ramió-Torrentà L, Montero P, Matías-Guiu J, Gómez-Estevez I, Oreja-Guevara C, Gil-Perotín S, Blanco Y, Carcelén M, Quintanilla-Bordás C, Costa L, Villar LM, Martínez-Rodriguez JE, Domínguez JA, Calles C, González I, Sotoca J, Oterino A, Lucas-Jimenez C, Pérez-Miralles F, Casanova B. Gascón-Giménez F, et al. Front Neurol. 2023 Mar 7;14:1060696. doi: 10.3389/fneur.2023.1060696. eCollection 2023. Front Neurol. 2023. PMID: 36959824 Free PMC article.
CSF markers in sleep neurobiology.
Martínez-Rodríguez JE, Santamaria J. Martínez-Rodríguez JE, et al. Clin Chim Acta. 2005 Dec;362(1-2):12-25. doi: 10.1016/j.cccn.2005.05.014. Epub 2005 Jun 29. Clin Chim Acta. 2005. PMID: 15992787 Review.
Adaptive Features of Natural Killer Cells in Multiple Sclerosis.
Moreira A, Alari-Pahissa E, Munteis E, Vera A, Zabalza A, Llop M, Villarrubia N, Costa-García M, Álvarez-Lafuente R, Villar LM, López-Botet M, Martínez-Rodríguez JE. Moreira A, et al. Among authors: martinez rodriguez je. Front Immunol. 2019 Oct 15;10:2403. doi: 10.3389/fimmu.2019.02403. eCollection 2019. Front Immunol. 2019. PMID: 31681293 Free PMC article. Clinical Trial.
Previous infection and stroke: a prospective study.
Roquer J, Cuadrado-Godia E, Giralt-Steinthauer E, Jimena S, Jiménez-Conde J, Martínez-Rodríguez JE, Ois A, Rodríguez-Campello A. Roquer J, et al. Cerebrovasc Dis. 2012;33(4):310-5. doi: 10.1159/000335306. Epub 2012 Feb 15. Cerebrovasc Dis. 2012. PMID: 22343923
Dynamics and Predictors of Cognitive Impairment along the Disease Course in Multiple Sclerosis.
Lopez-Soley E, Martinez-Heras E, Andorra M, Solanes A, Radua J, Montejo C, Alba-Arbalat S, Sola-Valls N, Pulido-Valdeolivas I, Sepulveda M, Romero-Pinel L, Munteis E, Martínez-Rodríguez JE, Blanco Y, Martinez-Lapiscina EH, Villoslada P, Saiz A, Solana E, Llufriu S. Lopez-Soley E, et al. Among authors: martinez rodriguez je. J Pers Med. 2021 Oct 28;11(11):1107. doi: 10.3390/jpm11111107. J Pers Med. 2021. PMID: 34834459 Free PMC article.
New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab.
Toboso I, Tejeda-Velarde A, Alvarez-Lafuente R, Arroyo R, Hegen H, Deisenhammer F, Sainz de la Maza S, Alvarez-Cermeño JC, Izquierdo G, Paramo D, Oliva P, Casanova B, Agüera-Morales E, Franciotta D, Gastaldi M, Fernández O, Urbaneja P, Garcia-Dominguez JM, Romero F, Laroni A, Uccelli A, Perez-Sempere A, Saiz A, Blanco Y, Galimberti D, Scarpini E, Espejo C, Montalban X, Rasche L, Paul F, González I, Álvarez E, Ramo C, Caminero AB, Aladro Y, Calles C, Eguía P, Belenguer-Benavides A, Ramió-Torrentà L, Quintana E, Martínez-Rodríguez JE, Oterino A, López de Silanes C, Casanova LI, Landete L, Frederiksen J, Bsteh G, Mulero P, Comabella M, Hernández MA, Espiño M, Prieto JM, Pérez D, Otano M, Padilla F, García-Merino JA, Navarro L, Muriel A, Frossard LC, Villar LM. Toboso I, et al. Among authors: martinez rodriguez je. Front Neurol. 2020 Dec 17;11:579438. doi: 10.3389/fneur.2020.579438. eCollection 2020. Front Neurol. 2020. PMID: 33408681 Free PMC article.
31 results